About the Nordic Migraine Symposium

Teva is a global company working in generics and innovative medicine. Teva is committed to bringing medicine, education and innovative solutions to health care professionals and with the ultimate goal of improving patient lives.

Aligned with this commitment, Teva Nordic Medical Affairs has since 2019 arranged an annual scientific symposium within migraine intended to be complementary to other international congresses and with highest clinical and scientific relevance. This series of symposia have top international migraine experts in the steering committee and as speakers. We strive to provide the speakers an opportunity to present their work/research in an environment facilitating interactions and discussions.

Teva is happy to announce that the 6th Nordic Migraine Symposium will be held in Stockholm, Sweden, 22-23rd of November 2024.

Steering Committee

Messoud Ashina
Professor of Neurology at Rigshospitalet Glostrup, Denmark.

Mattias Linde
Professor of Neurology in the Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, and Consultant Neurologist at the Sahlgrenska University Hospital, Gothenburg, Sweden

Marja-Liisa Sumelahti
Associate Professor at Tampere University, Neurologist at Terveystalo Tampere, Finland

Anne Christine Poole
General practitioner and headache specialist at Oslo Headache Center AS, Norway.  


If you have any questions regarding the symposium, please contact your local Teva Medical Affairs representative:

Denmark: Nadeem Mohammad / +45 236 604 04
Sweden: Fredrik Blomstrand / +46 706 689 003
Norway: Ole Henrik Osen / +47 415 450 75
Finland: Kari Alhainen / +358 40 809 9531
Belgium: Ahmet Krasniqi / +324 84 469 695


On behalf of the Steering Committee and Teva Neuroscience